{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:38:58Z","timestamp":1768030738219,"version":"3.49.0"},"reference-count":85,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1212\/con.0000000000000448","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T11:15:38Z","timestamp":1491390938000},"page":"533-552","source":"Crossref","is-referenced-by-count":4,"title":["Urogenital Symptoms in Neurologic Patients"],"prefix":"10.1212","volume":"23","author":[{"given":"Jalesh N.","family":"Panicker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"6","key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrn2401","article-title":"The neural control of micturition","volume":"9","author":"Fowler CJ","year":"2008","unstructured":"Fowler CJ Griffiths D de Groat WC. The neural control of micturition. Nat Rev Neurosci 2008;9(6):453\u2013466. doi:10.1038\/nrn2401.","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S1474-4422(15)00070-8","article-title":"Lower urinary tract dysfunction in the neurological patient: clinical assessment and management","volume":"14","author":"Panicker JN","year":"2015","unstructured":"Panicker JN Fowler CJ Kessler TM. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol 2015;14(7):720\u2013732. doi:10.1016\/S1474-4422(15)00070-8.","journal-title":"Lancet Neurol"},{"issue":"7","key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/0269215509353252","article-title":"Rehabilitation in Practice: neurogenic lower urinary tract dysfunction and its management","volume":"24","author":"Panicker JN","year":"2010","unstructured":"Panicker JN de S\u00e8ze M Fowler CJ. Rehabilitation in Practice: neurogenic lower urinary tract dysfunction and its management. Clin Rehabil 2010;24(7):579\u2013589. doi:10.1177\/0269215509353252.","journal-title":"Clin Rehabil"},{"issue":"2","key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000054774","article-title":"Renal failure in patients with neurogenic lower urinary tract dysfunction","volume":"20","author":"Lawrenson R","year":"2001","unstructured":"Lawrenson R Wyndaele JJ Vlachonikolis I. Renal failure in patients with neurogenic lower urinary tract dysfunction. Neuroepidemiology 2001;20(2):138\u2013143. doi:10.1159\/000054774.","journal-title":"Neuroepidemiology"},{"issue":"1","key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/nau.22495","article-title":"Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients","volume":"34","author":"Castel-Lacanal E","year":"2015","unstructured":"Castel-Lacanal E Gam\u00e9 X Clanet M. Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients. Neurourol Urodyn 2015;34(1):32\u201336. doi:10.1002\/nau.22495.","journal-title":"Neurourol Urodyn"},{"issue":"7","key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/sc.2011.193","article-title":"Bladder dysfunction in hereditary spastic paraplegia: a clinical and urodynamic evaluation","volume":"50","author":"Fourtassi M","year":"2012","unstructured":"Fourtassi M Jacquin-Courtois S Scheiber-Nogueira MC. Bladder dysfunction in hereditary spastic paraplegia: a clinical and urodynamic evaluation. Spinal Cord 2012;50(7):558\u2013562. doi:10.1038\/sc.2011.193.","journal-title":"Spinal Cord"},{"issue":"1","key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02089401","article-title":"Disturbances of bladder and urethral function in Parkinson\u2019s disease","volume":"17","author":"Andersen JT","year":"1985","unstructured":"Andersen JT. Disturbances of bladder and urethral function in Parkinson\u2019s disease. Int Urol Nephrol 1985;17(1):35\u201341.","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0022-5347(17)43390-8","article-title":"Urodynamic findings in Parkinson\u2019s disease","volume":"138","author":"Berger Y","year":"1987","unstructured":"Berger Y Blaivas JG DeLaRocha ER Salinas JM. Urodynamic findings in Parkinson\u2019s disease. J Urol 1987;138(4):836\u2013838.","journal-title":"J Urol"},{"issue":"2","key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s10286-005-0253-z","article-title":"Symptoms of autonomic failure in Parkinson\u2019s disease: prevalence and impact on daily life","volume":"15","author":"Magerkurth C","year":"2005","unstructured":"Magerkurth C Schnitzer R Braune S. Symptoms of autonomic failure in Parkinson\u2019s disease: prevalence and impact on daily life. Clin Auton Res 2005;15(2):76\u201382. doi:10.1007\/s10286-005-0253-z.","journal-title":"Clin Auton Res"},{"issue":"11","key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s00415-005-0855-3","article-title":"Falls in outpatients with Parkinson\u2019s disease: frequency, impact and identifying factors","volume":"252","author":"Balash Y","year":"2005","unstructured":"Balash Y Peretz C Leibovich G. Falls in outpatients with Parkinson\u2019s disease: frequency, impact and identifying factors. J Neurol 2005;252(11):1310\u20131315. doi:10.1007\/s00415-005-0855-3.","journal-title":"J Neurol"},{"issue":"3","key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jech.44.3.246","article-title":"Handicaps associated with incontinence: implications for management","volume":"44","author":"McGrother CW","year":"1990","unstructured":"McGrother CW Jagger C Clarke M Castleden CM. Handicaps associated with incontinence: implications for management. J Epidemiol Community Health 1990;44(3):246\u2013248. doi:10.1136\/jech.44.3.246.","journal-title":"J Epidemiol Community Health"},{"issue":"2","key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/mdc3.12279","article-title":"Nocturia in patients with Parkinson\u2019s disease","volume":"3","author":"Smith M","year":"2016","unstructured":"Smith M Seth J Batla A. Nocturia in patients with Parkinson\u2019s disease. Mov Disord Clin Pract 2016;3(2):168\u201372. doi:10.1002\/mdc3.12279.","journal-title":"Mov Disord Clin Pract"},{"issue":"5","key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/nau.22764","article-title":"A guideline for the management of bladder dysfunction in Parkinson\u2019s disease and other gait disorders","volume":"35","author":"Sakakibara R","year":"2016","unstructured":"Sakakibara R Panicker J Finazzi-Agro E. A guideline for the management of bladder dysfunction in Parkinson\u2019s disease and other gait disorders. Neurourol Urodyn 2016;35(5):551\u2013563. doi:10.1002\/nau.22764.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.22519","article-title":"Genitourinary dysfunction in Parkinson\u2019s disease","volume":"25","author":"Sakakibara R","year":"2010","unstructured":"Sakakibara R Uchiyama T Yamanishi T Kishi M. Genitourinary dysfunction in Parkinson\u2019s disease. Mov Disord 2010;25(1):2\u201312. doi:10.1002\/mds.22519.","journal-title":"Mov Disord"},{"issue":"5","key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/jnnp.71.5.600","article-title":"Videourodynamic and sphincter motor unit potential analyses in Parkinson\u2019s disease and multiple system atrophy","volume":"71","author":"Sakakibara R","year":"2001","unstructured":"Sakakibara R Hattori T Uchiyama T Yamanishi T. Videourodynamic and sphincter motor unit potential analyses in Parkinson\u2019s disease and multiple system atrophy. J Neurol Neurosurg Psychiatry 2001;71(5):600\u2013606. doi:10.1136\/jnnp.71.5.600.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/nau.20547","article-title":"Mechanism of bladder dysfunction in idiopathic normal pressure hydrocephalus","volume":"27","author":"Sakakibara R","year":"2008","unstructured":"Sakakibara R Kanda T Sekido T. Mechanism of bladder dysfunction in idiopathic normal pressure hydrocephalus. Neurourol Urodyn 2008;27(6):507\u2013510. doi:10.1002\/nau.20547.","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1212\/01.wnl.0000296826.61499.26","article-title":"Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease","volume":"70","author":"Ransmayr GN","year":"2008","unstructured":"Ransmayr GN Holliger S Schletterer K. Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease. Neurology 2008;70(4):299\u2013303. doi:10.1212\/01.wnl.0000296826.61499.26.","journal-title":"Neurology"},{"issue":"5","key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1532-5415.2008.01681.x","article-title":"Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes","volume":"56","author":"Sink KM","year":"2008","unstructured":"Sink KM Thomas J3rd Xu H. Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes. J Am Geriatr Soc 2008;56(5):847\u2013853. doi:10.1111\/j.1532-5415.2008.01681.x.","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/gerona\/glp037","article-title":"Localization of brain white matter hyperintensities and urinary incontinence in community-dwelling older adults","volume":"64","author":"Kuchel GA","year":"2009","unstructured":"Kuchel GA Moscufo N Guttmann CR. Localization of brain white matter hyperintensities and urinary incontinence in community-dwelling older adults. J Gerontol A Biol Sci Med Sci 2009;64(8):902\u2013909. doi:10.1093\/gerona\/glp037.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"7","key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1468-1331.2008.02184.x","article-title":"Post-stroke sexual functioning in first stroke patients","volume":"15","author":"Tamam Y","year":"2008","unstructured":"Tamam Y Tamam L Akil E. Post-stroke sexual functioning in first stroke patients. Eur J Neurol 2008;15(7):660\u2013666. doi:10.1111\/j.1468-1331.2008.02184.x.","journal-title":"Eur J Neurol"},{"issue":"7","key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/1352458506075651","article-title":"The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines","volume":"13","author":"de S\u00e8ze M","year":"2007","unstructured":"de S\u00e8ze M Ruffion A Denys P. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler 2007;13(7):915\u2013928. doi:10.1177\/1352458506075651.","journal-title":"Mult Scler"},{"issue":"10","key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/qjmed\/hch105","article-title":"What drives quality of life in multiple sclerosis?","volume":"97","author":"Hemmett L","year":"2004","unstructured":"Hemmett L Holmes J Barnes M Russell N. What drives quality of life in multiple sclerosis? QJM 2004;97(10):671\u2013676.","journal-title":"QJM"},{"issue":"1","key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0022-3859.62425","article-title":"Descriptive study of acute disseminated encephalomyelitis and evaluation of functional outcome predictors","volume":"56","author":"Panicker JN","year":"2010","unstructured":"Panicker JN Nagaraja D Kovoor JM Subbakrishna DK. Descriptive study of acute disseminated encephalomyelitis and evaluation of functional outcome predictors. J Postgrad Med 2010;56(1):12\u201316. doi:10.4103\/0022-3859.62425.","journal-title":"J Postgrad Med"},{"issue":"8","key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/1352458508093619","article-title":"The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis","volume":"14","author":"Tepavcevic D","year":"2008","unstructured":"Tepavcevic D Kostic J Basuroski I. The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis. Mult Scler 2008;14(8):1131\u20131136. doi:10.1177\/1352458508093619.","journal-title":"Mult Scler"},{"issue":"1","key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/1352458506071210","article-title":"Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis","volume":"13","author":"Nortvedt MW","year":"2007","unstructured":"Nortvedt MW Riise T Frug\u00e5rd J. Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Mult Scler 2007;13(1):106\u2013112. doi:10.1177\/1352458506071210","journal-title":"Mult Scler"},{"issue":"6","key":"e_1_3_2_27_2","first-page":"418","article-title":"Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups","volume":"5","author":"Zorzon M","year":"1999","unstructured":"Zorzon M Zivadinov R Bosco A. Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups. Mult Scler 1999;5(6):418\u2013427.","journal-title":"Mult Scler"},{"issue":"1","key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(01)00493-2","article-title":"Sexual dysfunction in multiple sclerosis: a 2-year follow-up study","volume":"187","author":"Zorzon M","year":"2001","unstructured":"Zorzon M Zivadinov R Monti Bragadin L. Sexual dysfunction in multiple sclerosis: a 2-year follow-up study. J Neurol Sci 2001;187(1\u20132):1\u20135. doi:10.1016\/S0022-510X(01)00493-2.","journal-title":"J Neurol Sci"},{"issue":"4","key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1191\/1352458504ms1060oa","article-title":"Bladder and sexual function among women with multiple sclerosis","volume":"10","author":"Borello-France D","year":"2004","unstructured":"Borello-France D Leng W O\u2019Leary M. Bladder and sexual function among women with multiple sclerosis. Mult Scler 2004;10(4):455\u2013461. doi:10.1191\/1352458504ms1060oa.","journal-title":"Mult Scler"},{"issue":"3","key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/01.ju.0000113145.43174.24","article-title":"Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis","volume":"171","author":"Dasgupta R","year":"2004","unstructured":"Dasgupta R Wiseman OJ Kanabar G. Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis. J Urol 2004;171(3):1189\u20131193; discussion 1193. doi:10.1097\/01.ju.0000113145.43174.24.","journal-title":"J Urol"},{"key":"e_1_3_2_31_2","volume-title":"Pelvic organ dysfunction in neurological disease clinical management and rehabilitation [Internet]","author":"Podnar S","year":"2010","unstructured":"Podnar S Fowler C. Pelvic organ dysfunction following cauda equina damage. In: Pelvic organ dysfunction in neurological disease clinical management and rehabilitation [Internet]. Cambridge: Cambridge University Press, 2010."},{"issue":"1","key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/1531-8249(200101)49:1<35::AID-ANA8>3.0.CO;2-J","article-title":"Sexual arousal and orgasm in women: effects of spinal cord injury","volume":"49","author":"Sipski ML","year":"2001","unstructured":"Sipski ML Alexander CJ Rosen R. Sexual arousal and orgasm in women: effects of spinal cord injury. Ann Neurol 2001;49(1):35\u201344. doi: 10.1002\/1531\u20138249(200101)49:1<35::AID-ANA8>3.0.CO;2-J.","journal-title":"Ann Neurol"},{"issue":"6","key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/jnnp.73.6.715","article-title":"Sexual function in men with cauda equina lesions: a clinical and electromyographic study","volume":"73","author":"Podnar S","year":"2002","unstructured":"Podnar S Oblak C Vodusek DB. Sexual function in men with cauda equina lesions: a clinical and electromyographic study. J Neurol Neurosurg Psychiatry 2002;73(6):715\u2013720.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/practneurol-2012-000478","article-title":"Urinary retention for the neurologist","volume":"13","author":"Smith MD","year":"2013","unstructured":"Smith MD Seth JH Fowler CJ. Urinary retention for the neurologist. Pract Neurol 2013;13(5):288\u2013291. doi:10.1136\/practneurol-2012-000478.","journal-title":"Pract Neurol"},{"issue":"2","key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.juro.2012.04.011","article-title":"The possible role of opiates in women with chronic urinary retention: observations from a prospective clinical study","volume":"188","author":"Panicker JN","year":"2012","unstructured":"Panicker JN Game X Khan S. The possible role of opiates in women with chronic urinary retention: observations from a prospective clinical study. J Urol 2012;188(2):480\u2013484. doi:10.1016\/j.juro.2012.04.011.","journal-title":"J Urol"},{"issue":"2","key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1464-410X.2007.07282.x","article-title":"Sacral neurostimulation for urinary retention: 10-year experience from one UK centre","volume":"101","author":"Datta SN","year":"2008","unstructured":"Datta SN Chaliha C Singh A. Sacral neurostimulation for urinary retention: 10-year experience from one UK centre. BJU Int 2008;101(2):192\u2013196. doi:10.1111\/j.1464-410X.2007.07282.x.","journal-title":"BJU Int"},{"issue":"5","key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/bju.13342","article-title":"Open-label study evaluating outpatient urethral sphincter injections of onabotulinumtoxinA to treat women with urinary retention due to a primary disorder of sphincter relaxation (Fowler\u2019s syndrome)","volume":"117","author":"Panicker JN","year":"2016","unstructured":"Panicker JN Seth JH Khan S. Open-label study evaluating outpatient urethral sphincter injections of onabotulinumtoxinA to treat women with urinary retention due to a primary disorder of sphincter relaxation (Fowler\u2019s syndrome). BJU Int 2016;117(5):809\u2013813. doi:10.1111\/bju.13342.","journal-title":"BJU Int"},{"issue":"2","key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/nau.10053","article-title":"The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"van Kerrebroeck P","year":"2002","unstructured":"van Kerrebroeck P Abrams P Chaikin D. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21(2):179\u2013183. doi:10.1002\/nau.10053.","journal-title":"Neurourol Urodyn"},{"issue":"11","key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1177\/014107689408701116","article-title":"The cost effectiveness of combined rapid tests (Multistix) in screening for urinary tract infections","volume":"87","author":"Fowlis GA","year":"1994","unstructured":"Fowlis GA Waters J Williams G. The cost effectiveness of combined rapid tests (Multistix) in screening for urinary tract infections. J R Soc Med 1994;87(11):681\u2013682. doi:10.1177\/014107689408701116.","journal-title":"J R Soc Med"},{"issue":"7","key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/1352458516633903","article-title":"Urinary tract infections in multiple sclerosis","volume":"22","author":"Ph\u00e9 V","year":"2016","unstructured":"Ph\u00e9 V Pakzad M Curtis C. Urinary tract infections in multiple sclerosis. Mult Scler 2016;22(7):855\u2013861. doi:10.1177\/1352458516633903.","journal-title":"Mult Scler"},{"issue":"5","key":"e_1_3_2_41_2","first-page":"470","article-title":"A UK consensus on the management of the bladder in multiple sclerosis","volume":"80","author":"Fowler CJ","year":"2009","unstructured":"Fowler CJ Panicker JN Drake M. A UK consensus on the management of the bladder in multiple sclerosis. J Neurol Neurosurg Psychiatry 2009;80(5):470\u2013477. doi:10.1136\/jnnp.2008.159178.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_2_42_2","unstructured":"National Institute for Health and Care Excellence. Urinary incontinence in neurological disease (CG148). nice.org.uk\/guidance\/cg148. Published August 2012. Accessed February 1 2017."},{"key":"e_1_3_2_43_2","unstructured":"Pannek J Blok B Castro-Diaz D. European Association of Urology Guidelines on neuro-urology 2014. uroweb.org\/gls\/pdf\/21. Limited update April 2014. Accessed February 1 2017."},{"issue":"1","key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/nau.20188","article-title":"Bladder dysfunction in patients with cauda equina lesions","volume":"25","author":"Podnar S","year":"2006","unstructured":"Podnar S Trsinar B Vodusek DB. Bladder dysfunction in patients with cauda equina lesions. Neurourol Urodyn 2006;25(1):23\u201331. doi:10.1002\/nau.20188.","journal-title":"Neurourol Urodyn"},{"issue":"11","key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/(SICI)1097-4598(199711)20:11<1396::AID-MUS7>3.0.CO;2-5","article-title":"Value of sphincter EMG in the diagnosis of multiple system strophy","volume":"20","author":"Palace J","year":"1997","unstructured":"Palace J Chandiramani VA Fowler CJ. Value of sphincter EMG in the diagnosis of multiple system strophy. Muscle Nerve 1997;20(11):1396\u20131403.","journal-title":"Muscle Nerve"},{"key":"e_1_3_2_46_2","volume-title":"Pelvic organ dysfunction in neurological disease clinical management and rehabilitation [Internet]","author":"Panicker J","year":"2010","unstructured":"Panicker J DasGupta R Elneil S Fowler C. Urinary retention. In: Pelvic organ dysfunction in neurological disease clinical management and rehabilitation [Internet]. Cambridge: Cambridge University Press, 2010."},{"issue":"5","key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.eururo.2012.02.036","article-title":"Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis","volume":"62","author":"Madhuvrata P","year":"2012","unstructured":"Madhuvrata P Singh M Hasafa Z Abdel-Fattah M. Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis. Eur Urol 2012;62(5):816\u2013830. doi:10.1016\/j.eururo.2012.02.036.","journal-title":"Eur Urol"},{"issue":"3","key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study","volume":"175","author":"Gray SL","year":"2015","unstructured":"Gray SL Anderson ML Dublin S. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med 2015;175(3):401\u2013407. doi:10.1001\/jamainternmed.2014.7663.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamaneurol.2016.0580","article-title":"Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults","volume":"73","author":"Risacher SL","year":"2016","unstructured":"Risacher SL McDonald BC Tallman EF. Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults. JAMA Neurol 2016;73(6):721\u2013732. doi:10.1001\/jamaneurol.2016.0580.","journal-title":"JAMA Neurol"},{"issue":"5","key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/ageing\/afu096","article-title":"Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review","volume":"43","author":"Fox C","year":"2014","unstructured":"Fox C Smith T Maidment I. Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing 2014;43(5):604\u2013615. doi:10.1093\/ageing\/afu096.","journal-title":"Age Ageing"},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.apha.2014.06.009","article-title":"P-glycoprotein trafficking as a therapeutic target to optimize CNS drug delivery","volume":"71","author":"Davis TP","year":"2014","unstructured":"Davis TP Sanchez-Covarubias L Tome ME. P-glycoprotein trafficking as a therapeutic target to optimize CNS drug delivery. Adv Pharmacol 2014;71:25\u201344. doi:10.1016\/bs.apha.2014.06.009.","journal-title":"Adv Pharmacol"},{"issue":"4","key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11597530-000000000-00000","article-title":"Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder","volume":"29","author":"Chancellor MB","year":"2012","unstructured":"Chancellor MB Staskin DR Kay GG. Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladder. Drugs Aging 2012;29(4):259\u2013273. doi:10.2165\/11597530-000000000-00000.","journal-title":"Drugs Aging"},{"issue":"9","key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1742-1241.2010.02449.x","article-title":"Review of cognitive impairment with antimuscarinic agents in elderly patients with overactive bladder","volume":"64","author":"Wagg A","year":"2010","unstructured":"Wagg A Verdejo C Molander U. Review of cognitive impairment with antimuscarinic agents in elderly patients with overactive bladder. Int J Clin Pract 2010;64(9):1279\u20131286. doi:10.1111\/j.1742-1241.2010.02449.x.","journal-title":"Int J Clin Pract"},{"issue":"8","key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s12603-009-0196-5","article-title":"Trospium and cognition in patients with late onset Alzheimer disease","volume":"13","author":"Isik AT","year":"2009","unstructured":"Isik AT Celik T Bozoglu E Doruk H. Trospium and cognition in patients with late onset Alzheimer disease. J Nutr Health Aging 2009;13(8):672\u2013676. doi:10.1007\/s12603\u2013009\u20130196\u20135.","journal-title":"J Nutr Health Aging"},{"issue":"1","key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/nau.22505","article-title":"Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability","volume":"33","author":"Chapple CR","year":"2014","unstructured":"Chapple CR Cardozo L Nitti VW. Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn 2014;33(1):17\u201330. doi:10.1002\/nau.22505.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"e_1_3_2_56_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.2005.00431.x","article-title":"Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis","volume":"112","author":"Bosma R","year":"2005","unstructured":"Bosma R Wynia K Havl\u00edkov\u00e1 E. Efficacy of desmopressin in patients with multiple sclerosis suffering from bladder dysfunction: a meta-analysis. Acta Neurol Scand 2005;112(1):1\u20135. doi:10.1111\/j.1600-0404.2005.00431.x.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"e_1_3_2_57_2","first-page":"692","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs?","volume":"164","author":"Schurch B","year":"2000","unstructured":"Schurch B St\u00f6hrer M Kramer G. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 2000;164(3 pt 1):692\u2013697. doi:10.1016\/S0022-5347(05)67283-7.","journal-title":"Preliminary results. J Urol"},{"issue":"9","key":"e_1_3_2_58_2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200003023420918","article-title":"Treatment of neurogenic incontinence with botulinum toxin A","volume":"342","author":"Schurch B","year":"2000","unstructured":"Schurch B Schmid DM St\u00f6hrer M. Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 2000;342(9):665. doi:10.1056\/NEJM200003023420918.","journal-title":"N Engl J Med"},{"issue":"4","key":"e_1_3_2_59_2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","article-title":"Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial","volume":"60","author":"Cruz F","year":"2011","unstructured":"Cruz F Herschorn S Aliotta P. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol 2011;60(4):742\u2013750. doi:10.1016\/j.eururo.2011.07.002.","journal-title":"Eur Urol"},{"issue":"6","key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","article-title":"Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity","volume":"187","author":"Ginsberg D","year":"2012","unstructured":"Ginsberg D Gousse A Keppenne V. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. J Urol 2012;187(6):2131\u20132139. doi:10.1016\/j.juro.2012.01.125.","journal-title":"J Urol"},{"issue":"3","key":"e_1_3_2_61_2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","article-title":"Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results","volume":"55","author":"Giannantoni A","year":"2009","unstructured":"Giannantoni A Mearini E Del Zingaro M Porena M. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results. Eur Urol 2009;55(3):705\u2013711. doi:10.1016\/j.eururo.2008.08.048.","journal-title":"Eur Urol"},{"issue":"3","key":"e_1_3_2_62_2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.urology.2012.11.010","article-title":"Long-term efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: an interim analysis","volume":"81","author":"Kennelly M","year":"2013","unstructured":"Kennelly M Dmochowski R Ethans K. Long-term efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: an interim analysis. Urology 2013;81(3):491\u2013497. doi:10.1016\/j.urology.2012.11.010.","journal-title":"Urology"},{"issue":"4","key":"e_1_3_2_63_2","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.juro.2009.12.036","article-title":"Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial","volume":"183","author":"Peters KM","year":"2010","unstructured":"Peters KM Carrico DJ Perez-Marrero RA. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol 2010;183(4):1438\u20131443. doi:10.1016\/j.juro.2009.12.036.","journal-title":"J Urol"},{"issue":"1","key":"e_1_3_2_64_2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/nau.20593","article-title":"Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson\u2019s disease","volume":"28","author":"Kabay SC","year":"2009","unstructured":"Kabay SC Kabay S Yucel M Ozden H. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson\u2019s disease. Neurourol Urodyn 2009;28(1):62\u201367. doi:10.1002\/nau.20593.","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"e_1_3_2_65_2","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/nau.20733","article-title":"The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction","volume":"28","author":"Kabay S","year":"2009","unstructured":"Kabay S Kabay SC Yucel M. The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction. Neurourol Urodyn 2009;28(8):964\u2013968. doi:10.1002\/nau.20733.","journal-title":"Neurourol Urodyn"},{"issue":"12","key":"e_1_3_2_66_2","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1177\/1352458511414040","article-title":"Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial","volume":"17","author":"Gobbi C","year":"2011","unstructured":"Gobbi C Digesu GA Khullar V. Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial. Mult Scler 2011;17(12):1514\u20131519. doi:10.1177\/1352458511414040.","journal-title":"Mult Scler"},{"issue":"3","key":"e_1_3_2_67_2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/nau.20958","article-title":"Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study","volume":"30","author":"de S\u00e8ze M","year":"2011","unstructured":"de S\u00e8ze M Raibaut P Gallien P. Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study. Neurourol Urodyn 2011;30(3):306\u2013311. doi:10.1002\/nau.20958.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"e_1_3_2_68_2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.urology.2014.05.031","article-title":"Electrical stimulation of the posterior tibialis nerve improves symptoms of poststroke neurogenic overactive bladder in men: a randomized controlled trial","volume":"84","author":"Monteiro \u00c9S","year":"2014","unstructured":"Monteiro \u00c9S de Carvalho LB Fukujima MM. Electrical stimulation of the posterior tibialis nerve improves symptoms of poststroke neurogenic overactive bladder in men: a randomized controlled trial. Urology 2014;84(3):509\u2013514. doi:10.1016\/j.urology.2014.05.031.","journal-title":"Urology"},{"issue":"6","key":"e_1_3_2_69_2","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.eururo.2010.09.024","article-title":"Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis","volume":"58","author":"Kessler TM","year":"2010","unstructured":"Kessler TM La Framboise D Trelle S. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol 2010;58(6):865\u2013874. doi:10.1016\/j.eururo.2010.09.024.","journal-title":"Eur Urol"},{"issue":"1","key":"e_1_3_2_70_2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/ana.21814","article-title":"Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury","volume":"67","author":"Sievert KD","year":"2010","unstructured":"Sievert KD Amend B Gakis G. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann Neurol 2010;67(1):74\u201384. doi:10.1002\/ana.21814.","journal-title":"Ann Neurol"},{"issue":"5","key":"e_1_3_2_71_2","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/nau.21096","article-title":"How does neuromodulation work","volume":"30","author":"Amend B","year":"2011","unstructured":"Amend B Matzel KE Abrams P. How does neuromodulation work. Neurourol Urodyn 2011;30(5):762\u2013765. doi:10.1002\/nau.21096.","journal-title":"Neurourol Urodyn"},{"key":"e_1_3_2_72_2","first-page":"191","article-title":"Ensuring patient adherence to clean intermittent self-catheterization","volume":"8","author":"Seth JH","year":"2014","unstructured":"Seth JH Haslam C Panicker JN. Ensuring patient adherence to clean intermittent self-catheterization. Patient Prefer Adherence 2014;8:191\u2013198. doi:10.2147\/PPA.S49060.","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"e_1_3_2_73_2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1191\/0269215503cr583oa","article-title":"Lower abdominal pressure versus external bladder stimulation to aid bladder emptying in multiple sclerosis: a randomized controlled study","volume":"17","author":"Prasad RS","year":"2003","unstructured":"Prasad RS Smith SJ Wright H. Lower abdominal pressure versus external bladder stimulation to aid bladder emptying in multiple sclerosis: a randomized controlled study. Clin Rehabil 2003;17(1):42\u20137. doi:10.1191\/0269215503cr583oa.","journal-title":"Clin Rehabil"},{"issue":"19","key":"e_1_3_2_74_2","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1212\/01.wnl.0000311390.87642.d8","article-title":"Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"70","author":"Naumann M","year":"2008","unstructured":"Naumann M So Y Argoff CE. Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008;70(19):1707\u20131714. doi:10.1212\/01.wnl.0000311390.87642.d8.","journal-title":"Neurology"},{"issue":"24","key":"e_1_3_2_75_2","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJM200006153422407","article-title":"Erectile dysfunction","volume":"342","author":"Lue TF","year":"2000","unstructured":"Lue TF. Erectile dysfunction. N Engl J Med 2000;342(24):1802\u20131813. doi:10.1056\/NEJM200006153422407.","journal-title":"N Engl J Med"},{"issue":"5","key":"e_1_3_2_76_2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/jnnp.2004.038695","article-title":"A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis","volume":"76","author":"Fowler CJ","year":"2005","unstructured":"Fowler CJ Miller JR Sharief MK. A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J Neurol Neurosurg Psychiatry 2005;76(5):700\u2013705. doi:10.1136\/jnnp.2004.038695.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"e_1_3_2_77_2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.juro.2008.09.003","article-title":"Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: a double-blind, placebo controlled, randomized study","volume":"181","author":"Safarinejad MR","year":"2009","unstructured":"Safarinejad MR. Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: a double-blind, placebo controlled, randomized study. J Urol 2009;181(1):252\u2013258. doi:10.1016\/j.juro.2008.09.003.","journal-title":"J Urol"},{"issue":"3","key":"e_1_3_2_78_2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jnnp.71.3.371","article-title":"Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson\u2019s disease or multiple system atrophy with observations on orthostatic hypotension","volume":"71","author":"Hussain IF","year":"2001","unstructured":"Hussain IF Brady CM Swinn MJ. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson\u2019s disease or multiple system atrophy with observations on orthostatic hypotension. J Neurol Neurosurg Psychiatry 2001;71(3):371\u2013374. doi:10.1136\/jnnp.71.3.371.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"e_1_3_2_79_2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0302-2838(02)00054-4","article-title":"Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson\u2019s disease","volume":"41","author":"Raffaele R","year":"2002","unstructured":"Raffaele R Vecchio I Giammusso B. Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson\u2019s disease. Eur Urol 2002;41(4):382\u2013386. doi:10.1016\/S0302-2838(02)00054-4.","journal-title":"Eur Urol"},{"issue":"12","key":"e_1_3_2_80_2","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1111\/j.1743-6109.2009.01426.x","article-title":"Ten-year follow-up of sildenafil use in spinal cord-injured patients with erectile dysfunction","volume":"6","author":"Lombardi G","year":"2009","unstructured":"Lombardi G Macchiarella A Cecconi F Del Popolo G. Ten-year follow-up of sildenafil use in spinal cord-injured patients with erectile dysfunction. J Sex Med 2009;6(12):3449\u20133457. doi:10.1111\/j.1743\u20136109.2009.01426.x.","journal-title":"J Sex Med"},{"issue":"2","key":"e_1_3_2_81_2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1743-6109.2008.01106.x","article-title":"Efficacy and safety of medium and long-term tadalafil use in spinal cord patients with erectile dysfunction","volume":"6","author":"Lombardi G","year":"2009","unstructured":"Lombardi G Macchiarella A Cecconi F Del Popolo G. Efficacy and safety of medium and long-term tadalafil use in spinal cord patients with erectile dysfunction. J Sex Med 2009;6(2):535\u2013543. doi:10.1111\/j.1743\u20136109.2008.01106.x.","journal-title":"J Sex Med"},{"issue":"2","key":"e_1_3_2_82_2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1212\/01.wnl.0000194260.43583.32","article-title":"Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury","volume":"66","author":"Giuliano F","year":"2006","unstructured":"Giuliano F Rubio-Aurioles E Kennelly M. Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury. Neurology 2006;66(2):210\u2013216. doi:10.1212\/01.wnl.0000194260.43583.32.","journal-title":"Neurology"},{"issue":"2","key":"e_1_3_2_83_2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0094-0143(05)70142-7","article-title":"Vacuum constriction and external erection devices in erectile dysfunction","volume":"28","author":"Levine LA","year":"2001","unstructured":"Levine LA Dimitriou RJ. Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am 2001;28(2):335\u201341, ix-x. doi:10.1016\/S0094-0143(05)70142-7.","journal-title":"Urol Clin North Am"},{"issue":"3","key":"e_1_3_2_84_2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0090-4295(94)90081-7","article-title":"Prospective comparison of topical minoxidil to vacuum constriction device and intracorporeal papaverine injection in treatment of erectile dysfunction due to spinal cord injury","volume":"43","author":"Chancellor MB","year":"1994","unstructured":"Chancellor MB Rivas DA Panzer DE. Prospective comparison of topical minoxidil to vacuum constriction device and intracorporeal papaverine injection in treatment of erectile dysfunction due to spinal cord injury. Urology 1994;43(3):365\u2013369. doi:10.1016\/0090-4295(94)90081-7.","journal-title":"Urology"},{"issue":"5","key":"e_1_3_2_85_2","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0022-5347(01)66142-1","article-title":"Outcome analysis of goal directed therapy for impotence","volume":"155","author":"Jarow JP","year":"1996","unstructured":"Jarow JP Nana-Sinkam P Sabbagh M Eskew A. Outcome analysis of goal directed therapy for impotence. J Urol 1996;155(5):1609\u20131612. doi:10.1016\/S0022-5347(01)66142-1.","journal-title":"J Urol"},{"issue":"5","key":"e_1_3_2_86_2","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.juro.2007.07.047","article-title":"Midodrine improves ejaculation in spinal cord injured men","volume":"178","author":"Soler JM","year":"2007","unstructured":"Soler JM Previnaire JG Plante P. Midodrine improves ejaculation in spinal cord injured men. J Urol 2007;178(5):2082\u20132086. doi:10.1016\/j.juro.2007.07.047.","journal-title":"J Urol"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00132979-201704000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:57:45Z","timestamp":1752155865000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["10.1212\/CON.0000000000000448"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000448","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}